{"id":"https://openalex.org/W3147845142","doi":"https://doi.org/10.1158/1538-7445.am2019-1017","title":"Abstract 1017: Novel inhibitors of AR-v7 nuclear import: new therapeutic opportunities for CRPC","display_name":"Abstract 1017: Novel inhibitors of AR-v7 nuclear import: new therapeutic opportunities for CRPC","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W3147845142","doi":"https://doi.org/10.1158/1538-7445.am2019-1017","mag":"3147845142"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2019-1017","doi":"https://doi.org/10.1158/1538-7445.am2019-1017","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-1017","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018582652","display_name":"Seaho Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seaho Kim","raw_affiliation_strings":["1Weill Cornell Medicine, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Weill Cornell Medicine, New York, NY;","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090983906","display_name":"Mohd Azrin Jamalruddin","orcid":"https://orcid.org/0000-0002-7408-6914","observed_orcids":["https://orcid.org/0000-0002-7408-6914"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohd Azrin Jamalruddin","raw_affiliation_strings":["1Weill Cornell Medicine, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Weill Cornell Medicine, New York, NY;","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059125341","display_name":"Eiman Mukhtar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eiman Mukhtar","raw_affiliation_strings":["1Weill Cornell Medicine, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Weill Cornell Medicine, New York, NY;","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084540001","display_name":"Michael J. Miller","orcid":"https://orcid.org/0000-0001-7990-3381","observed_orcids":["https://orcid.org/0000-0001-7990-3381"]},"institutions":[{"id":"https://openalex.org/I4210153054","display_name":"Tri-Institutional Therapeutics Discovery Institute","ror":"https://ror.org/053z9p797","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210153054"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Miller","raw_affiliation_strings":["2Tri-Institutional Therapeutics Discovery Institute, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Tri-Institutional Therapeutics Discovery Institute, New York, NY","institution_ids":["https://openalex.org/I4210153054"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067755139","display_name":"Leigh A. Baxt","orcid":"https://orcid.org/0000-0001-8286-3907","observed_orcids":["https://orcid.org/0000-0001-8286-3907"]},"institutions":[{"id":"https://openalex.org/I4210153054","display_name":"Tri-Institutional Therapeutics Discovery Institute","ror":"https://ror.org/053z9p797","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210153054"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leigh Baxt","raw_affiliation_strings":["2Tri-Institutional Therapeutics Discovery Institute, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Tri-Institutional Therapeutics Discovery Institute, New York, NY","institution_ids":["https://openalex.org/I4210153054"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027177687","display_name":"Stacia Kargman","orcid":"https://orcid.org/0000-0002-0148-8883","observed_orcids":["https://orcid.org/0000-0002-0148-8883"]},"institutions":[{"id":"https://openalex.org/I4210153054","display_name":"Tri-Institutional Therapeutics Discovery Institute","ror":"https://ror.org/053z9p797","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210153054"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stacia Kargman","raw_affiliation_strings":["2Tri-Institutional Therapeutics Discovery Institute, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Tri-Institutional Therapeutics Discovery Institute, New York, NY","institution_ids":["https://openalex.org/I4210153054"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053281425","display_name":"Andrew W. Stamford","orcid":"https://orcid.org/0000-0003-0693-3461","observed_orcids":["https://orcid.org/0000-0003-0693-3461"]},"institutions":[{"id":"https://openalex.org/I4210153054","display_name":"Tri-Institutional Therapeutics Discovery Institute","ror":"https://ror.org/053z9p797","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210153054"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Stamford","raw_affiliation_strings":["2Tri-Institutional Therapeutics Discovery Institute, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Tri-Institutional Therapeutics Discovery Institute, New York, NY","institution_ids":["https://openalex.org/I4210153054"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036666565","display_name":"Peter T. Meinke","orcid":"https://orcid.org/0000-0002-7548-6215","observed_orcids":["https://orcid.org/0000-0002-7548-6215"]},"institutions":[{"id":"https://openalex.org/I4210153054","display_name":"Tri-Institutional Therapeutics Discovery Institute","ror":"https://ror.org/053z9p797","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210153054"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Meinke","raw_affiliation_strings":["2Tri-Institutional Therapeutics Discovery Institute, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Tri-Institutional Therapeutics Discovery Institute, New York, NY","institution_ids":["https://openalex.org/I4210153054"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071996306","display_name":"Paraskevi Giannakakou","orcid":"https://orcid.org/0000-0001-7378-262X","observed_orcids":["https://orcid.org/0000-0001-7378-262X"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paraskevi Giannakakou","raw_affiliation_strings":["1Weill Cornell Medicine, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Weill Cornell Medicine, New York, NY;","institution_ids":["https://openalex.org/I4387153466"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"13_Supplement","first_page":"1017","last_page":"1017"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ar-v7","display_name":"AR-V7","score":0.7450000047683716},{"id":"https://openalex.org/keywords/ar-splice-variants","display_name":"androgen receptor splice variants","score":0.9210000038146973},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9120000004768372},{"id":"https://openalex.org/keywords/nuclear-import-inhibition","display_name":"nuclear import inhibition","score":0.8379999995231628},{"id":"https://openalex.org/keywords/dimerization-domain","display_name":"dimerization domain","score":0.781000018119812},{"id":"https://openalex.org/keywords/enzalutamide-resistance","display_name":"enzalutamide resistance","score":0.8429999947547913},{"id":"https://openalex.org/keywords/abiraterone-resistance","display_name":"abiraterone resistance","score":0.9409999847412109},{"id":"https://openalex.org/keywords/taxane-resistance","display_name":"taxane resistance","score":0.9259999990463257},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.656000018119812},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8230000138282776},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.5879999995231628},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.8149999976158142},{"id":"https://openalex.org/keywords/transcriptional-activity-inhibition","display_name":"transcriptional activity inhibition","score":0.6449999809265137},{"id":"https://openalex.org/keywords/wheat-germ-agglutinin","display_name":"wheat germ agglutinin","score":0.7570000290870667}],"concepts":[{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.7474666833877563},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.6050376892089844},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5543397068977356},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.5361303091049194},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.4915398061275482},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4393547773361206},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3050263524055481},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2845294177532196},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2489394247531891},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14511805772781372},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2019-1017","doi":"https://doi.org/10.1158/1538-7445.am2019-1017","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-1017","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282928070","https://openalex.org/W4285731041","https://openalex.org/W2498448966","https://openalex.org/W2740897557","https://openalex.org/W7154749121","https://openalex.org/W4393072593","https://openalex.org/W2005684073","https://openalex.org/W4393191283","https://openalex.org/W1661420266","https://openalex.org/W7131355310"],"abstract_inverted_index":{"Abstract":[0],"Reactivation":[1],"of":[2,14,17,70,96,161,183,256,297,306,318,333,366,428,440],"androgen":[3],"receptor":[4],"(AR)":[5],"signaling":[6,81],"by":[7,82,226],"active":[8,85,142],"splice":[9],"variants":[10],"(AR-Vs)":[11],"is":[12,24,74,99,175,187],"one":[13],"key":[15],"drivers":[16],"castration":[18],"resistant":[19],"prostate":[20],"cancer":[21],"(CRPC).":[22],"AR-v7":[23,72,78,112,118,148,162,206,214,261,307,319,337,354,383,429],"the":[25,42,62,87,93,120,127,173,283,298,345,353,381,403,441],"most":[26,284],"prevalent":[27],"AR-V":[28],"and":[29,46,59,115,243,387],"its":[30,168],"expression":[31],"has":[32,108],"been":[33],"clinically":[34,189,390],"associated":[35,101],"with":[36,56,102,217,237,375,392],"poor":[37],"overall":[38],"survival,":[39],"resistance":[40],"to":[41,140,167,200,254,277,281,352,358],"AR":[43,57,80,97,184,394],"inhibitors":[44,58,73,427],"enzalutamide":[45],"abiraterone,":[47],"as":[48,50,329,331],"well":[49,330],"taxane":[51,90],"resistance.":[52],"Given":[53],"that":[54,172,203,259,379],"treatment":[55],"taxanes":[60],"are":[61,275,312,343],"only":[63],"effective":[64],"therapeutic":[65,191,433],"modalities":[66],"in":[67,86,105,147,215,288,336],"CRPC,":[68,106],"development":[69,365],"specific":[71,303],"urgently":[75],"needed.":[76],"Mechanistically,":[77,117],"re-activates":[79],"being":[83],"constitutively":[84],"nucleus.":[88],"While":[89],"chemotherapy":[91],"inhibits":[92],"nuclear":[94,113,134,144,179,185,207,262,308,361,384,430],"import":[95,186,385],"which":[98,274],"significantly":[100],"clinical":[103],"outcomes":[104],"it":[107],"no":[109],"effect":[110],"on":[111,316],"localization":[114],"activity.":[116],"lacks":[119],"microtubule-binding":[121],"domain":[122,164,356],"and\u2014unlike":[123],"AR\u2014does":[124],"not":[125,400],"utilize":[126],"canonical":[128],"importin-\u03b1/\u03b2":[129],"pathway,":[130],"or":[131,357],"RanGTP":[132],"for":[133,154,178,287,348,435,444],"import.":[135,180,208,263,309],"Using":[136,209,291],"wheat":[137],"germ":[138],"agglutinin":[139],"block":[141],"protein":[143],"uptake":[145],"resulted":[146],"cytoplasmic":[149,169],"sequestration,":[150,170],"indicating":[151,171],"a":[152,188,195,248],"requirement":[153],"an":[155,218],"alternative":[156,360],"transport":[157,362],"receptor.":[158],"Further,":[159],"mutation":[160],"dimerization":[163,355],"(D-box)":[165],"led":[166,253],"D-box":[174],"also":[176],"required":[177],"As":[181],"inhibition":[182,305,317,332],"validated":[190],"strategy,":[192],"we":[193,222,301,311,342],"developed":[194],"novel":[196,373],"drug":[197],"discovery":[198],"platform":[199],"identify":[201,282],"compounds":[202,225,258,266,294],"specifically":[204],"inhibit":[205,260],"cells":[210,328],"stably":[211],"expressing":[212],"inducible":[213],"conjunction":[216],"enzyme":[219],"complementation":[220],"assay":[221],"tested":[223],"166,000":[224],"high":[227],"throughput":[228],"screening":[229],"(HTS).":[230],"The":[231,264],"robust":[232],"HTS":[233],"performance":[234],"(Z>0.8)":[235],"together":[236],"subsequent":[238],"counter":[239],"screens":[240],"including":[241,326],"confirmation":[242],"compound":[244,286,347],"titration,":[245],"cell":[246,324],"toxicity,":[247],"tertiary":[249],"imaging":[250],"based":[251],"screen,":[252],"identification":[255],"lead":[257,265,346,368],"share":[267],"structural":[268],"features,":[269],"across":[270,322],"two":[271,299],"main":[272],"chemotypes,":[273,300,374],"amenable":[276],"structure-activity":[278],"relationship":[279],"studies":[280],"desirable":[285,376],"vivo":[289],"studies.":[290],"newly":[292],"synthesized":[293],"from":[295],"each":[296],"showed":[302],"dose-dependent":[304],"Currently,":[310],"testing":[313,344],"these":[314],"compounds,":[315],"transcriptional":[320],"activity":[321],"several":[323],"models":[325],"enzalutamide-resistant":[327],"tumor":[334],"growth":[335],"xenograft":[338],"models.":[339],"In":[340],"parallel":[341],"potential":[349],"direct":[350],"binding":[351],"candidate":[359],"receptors.":[363],"Further":[364],"our":[367],"small":[369],"molecules":[370],"will":[371],"yield":[372],"pharmacological":[377],"properties":[378],"target":[380],"unique":[382],"pathway":[386],"can":[388],"be":[389],"combined":[391],"existing":[393],"therapies.":[395],"Note:":[396],"This":[397],"abstract":[398],"was":[399],"presented":[401],"at":[402],"meeting.":[404],"Citation":[405],"Format:":[406],"Seaho":[407],"Kim,":[408],"Mohd":[409],"Azrin":[410],"Jamalruddin,":[411],"Eiman":[412],"Mukhtar,":[413],"Michael":[414],"Miller,":[415],"Leigh":[416],"Baxt,":[417],"Stacia":[418],"Kargman,":[419],"Andrew":[420],"Stamford,":[421],"Peter":[422],"Meinke,":[423],"Paraskevi":[424],"Giannakakou.":[425],"Novel":[426],"import:":[431],"new":[432],"opportunities":[434],"CRPC":[436],"[abstract].":[437],"In:":[438],"Proceedings":[439],"American":[442],"Association":[443],"Cancer":[445,459],"Research":[446],"Annual":[447],"Meeting":[448],"2019;":[449],"2019":[450],"Mar":[451],"29-Apr":[452],"3;":[453],"Atlanta,":[454],"GA.":[455],"Philadelphia":[456],"(PA):":[457],"AACR;":[458],"Res":[460],"2019;79(13":[461],"Suppl):Abstract":[462],"nr":[463],"1017.":[464]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2021-04-13T00:00:00"}